Core Insights - Shenzhen Sailu Life Science Co., Ltd. has been established with a registered capital of 3 million RMB, fully owned by Shenzhen Sailu Medical Technology Co., Ltd. [1] Company Overview - The legal representative of Shenzhen Sailu Life Science Co., Ltd. is Zhao Luyang [1] - The company is classified as a limited liability company (sole proprietorship) [1] - The business scope includes the sale and production of medical devices, technical services, health consulting, and the development of gene diagnosis and treatment technologies [1] Business Operations - The company operates in the scientific research and technical service industry, specifically in engineering and technology research and experimental development [1] - The registered address is located in the Heng Tai Yu Building, Shenzhen [1] - The business license allows for various activities, including the import and export of goods and technology [1]

Core Viewpoint - Chongqing Jiuxian Biotechnology Co., Ltd. has been established with a registered capital of 20 million RMB, fully owned by Chongqing Jiuzhe Chengshi Agricultural Technology Co., Ltd. [1] Company Information - Company Name: Chongqing Jiuxian Biotechnology Co., Ltd. [1] - Legal Representative: Zhang Huanying [1] - Registered Capital: 20 million RMB [1] - Shareholding Structure: 100% owned by Chongqing Jiuzhe Chengshi Agricultural Technology Co., Ltd. [1] - Business Scope: Includes edible mushroom strain production, food production and sales, technical services, and agricultural product processing [1] Industry Classification - National Standard Industry: Scientific research and technical service industry, specifically engineering and technical research and experimental development [1] - Business Address: Chongqing City, Qianjiang District, Zhengyang Street, Chongqing Zhengyang Industrial Park [1] - Company Type: Limited liability company (wholly owned by a natural person) [1] - Business Duration: Until August 25, 2025, with no fixed term thereafter [1] - Registration Authority: Market Supervision Administration of Qianjiang District, Chongqing City [1]

Core Insights - Lianyungang Tongyuan Cell Gene Engineering Co., Ltd. has been established with a registered capital of 3 million RMB, fully owned by Tongyuan Pathology Diagnosis Center (Jiangsu) Co., Ltd. [1] Company Overview - The legal representative of the company is Pan Jiagan [1] - The company is classified under the scientific research and technical service industry, specifically in engineering and technical research and development [1] - The business address is located at No. 567 Huaguoshan Avenue, Building 5, 6th Floor, China Medicine Port, Lianyungang Economic and Technological Development Zone [1] Business Scope - The company's business scope includes medical beauty services, life beauty services, drug clinical trial services, cosmetics production, leasing of Class III medical equipment, and operation of Class III medical devices [1] - It also involves cell technology research and application, engineering and technical research and experimental development, human stem cell technology development and application, and various technical services [1] - Additional services include internet data services, big data services, and sales of medical devices and cosmetics [1]

Group 1 - A new company, Yinuo Pharmaceutical (Shenzhen) Co., Ltd., has been established with a registered capital of 10 million RMB, fully owned by Yinuo Pharmaceutical (Guangdong) Co., Ltd. [1] - The legal representative of Yinuo Pharmaceutical (Shenzhen) Co., Ltd. is Zhu Yijun [1]. - The company is located at 11 Jinniu West Road, Yike Building, Longtian Street, Pingshan District, Shenzhen [2]. Group 2 - Yinuo Pharmaceutical (Guangdong) Co., Ltd. holds 100% ownership of Yinuo Pharmaceutical (Shenzhen) Co., Ltd. [2]. - The business scope includes medical research and experimental development, technology services, and health consulting services, among others [2]. - The company is authorized to engage in drug import and export, drug retail, clinical trial services, and medical services, subject to regulatory approval [2].

Group 1 - Shanghai Zhifang Yuansheng Technology Co., Ltd. has been established with a registered capital of 5 million RMB [1] - The company is wholly owned by Shanghai Zhifang Digong Technology Co., Ltd. [1] - The legal representative of the company is Zhang Xiyong [1] Group 2 - The business scope includes technology services, development, consulting, and transfer, as well as cell technology research and application [1] - The company is involved in human stem cell technology development and medical research and experimental development [1] - It also offers health consulting services, medical device sales, and marketing planning [1] Group 3 - The company is classified under the national standard industry of scientific research and technical services, specifically in engineering and technical research and experimental development [1] - The registered address is Room 405, Building 1, No. 38 Guokang Road, Yangpu District, Shanghai [1] - The business license allows for independent operation of activities not requiring approval [1]

Group 1 - Shanghai Guoji Zhili Technology Co., Ltd. was recently established with a registered capital of 10 million RMB [1][2] - The legal representative of the company is Zhao Yinkai [2] - The company has multiple shareholders, including Hangzhou Ruiya Education Technology Co., Ltd. (40%), Zhongfang Anhu Emergency Education Technology (Beijing) Co., Ltd. (23%), and Hebei Feisike Human Resources Service Co., Ltd. (15%) [1] Group 2 - The company's business scope includes technology services, software development, human resources services (excluding employment agency activities), import and export of goods, and technology import and export [1] - The company is also involved in various licensed projects such as construction engineering, network culture operations, and second-class value-added telecommunications services [1] - Key projects include the development of artificial intelligence software, cultural exchange activities, marketing planning, and sales of educational instruments and security equipment [1]

Company Overview - Chengdu Xinyao Jingguo Agricultural Technology Co., Ltd. has been established with a registered capital of 11.8888 million RMB [1] - The legal representative of the company is Xiang Wei [1] - The company is classified under the national standard industry of scientific research and technical services, specifically in research and experimental development [1] Shareholding Structure - The shareholding structure consists of three main shareholders: - Emei City Xinqichao Mineral Products Sales Co., Ltd. holds 80% of the shares [1] - Sichuan Hengyao Tianxia Environmental Technology Co., Ltd. holds 10% of the shares [1] - Emei City Huawei Xinwo Trading Co., Ltd. holds 10% of the shares [1] Business Scope - The business scope includes: - Agricultural scientific research and experimental development [1] - Smart agricultural management [1] - Agricultural production management services [1] - Internet sales (excluding items requiring permits) [1] - Sales of agricultural by-products and traditional Chinese medicine procurement [1] - Wholesale of edible agricultural products [1] - Development and operation of rural folk crafts, leisure agriculture, and rural tourism resources [1] - Sales of forestry products and grains [1] - Packaging services [1]

Company Overview - Hangzhou Paitesis Biomedical Technology Co., Ltd. was recently established with a registered capital of 3 million RMB [1][2] - The legal representative of the company is Jin Bolan [2] Shareholding Structure - The shareholding structure is as follows: - Shanghai Feichangmei Cosmetics Co., Ltd. holds 63% - Weidao (Hangzhou) Network Technology Co., Ltd. holds 27% - Huangshan Chuyuan Biotechnology Co., Ltd. holds 10% [1] Business Scope - The company's business scope includes: - Medical research and experimental development - Research and experimental development (excluding human stem cells, gene diagnosis, and treatment technology development and application) - Cell technology research and application - Natural science research and experimental development - Human stem cell technology development and application - Wholesale of pet food and supplies - Research and development of biological feed - Sales of livestock and fishery feed - Sales of feed raw materials - Retail of pet food and supplies - Technical services, development, consulting, exchange, transfer, and promotion - Wholesale of arts and crafts and collectibles (excluding ivory and its products) - Sales of arts and crafts and ceremonial supplies (excluding ivory and its products) - Sales of electronic products - Import and export of goods and technology (excluding projects that require approval) [1] Licensing Projects - The company is authorized to engage in: - Retail of pharmaceuticals - Clinical trial services for drugs - Animal diagnosis and treatment (subject to approval by relevant authorities) [1]

Group 1 - The establishment of Zhongyi (Shenzhen) Biopharmaceutical Co., Ltd. has been registered with a capital of 3.1313 million RMB [1] - The company is primarily owned by Zhongyi (Guangdong) Petroleum Energy Co., Ltd. with a 54% stake, followed by Guizhou Tianyi Hongyun Liquor Industry (Group) Co., Ltd. with 33%, and Chen Tianhe with 13% [1] - The business scope includes special medical purpose formula food sales, medical research and experimental development, biomedical engineering technology services, traditional Chinese medicine extraction, and various other health-related products and services [1] Group 2 - The company is classified under the national standard industry of scientific research and technical services, specifically focusing on research and experimental development [1] - The registered address is located in Nanshan District, Shenzhen, with a business duration until August 20, 2025, and no fixed term thereafter [1] - The company is structured as a limited liability company and is subject to various regulatory approvals for its licensed business activities [1]

Company Overview - Zhongjian Helian (Suzhou) Pharmaceutical Technology Co., Ltd. has been established with a registered capital of 40 million RMB [1] - The legal representative is Zhu Zihang, and the company is co-owned by China Inspection and Certification Group Guangdong Co., Ltd. (51%) and Xihua (Suzhou) Pharmaceutical Technology Co., Ltd. (49%) [1] Business Scope - The company’s business scope includes the production of radioactive isotopes (excluding radiopharmaceuticals for positron emission tomography), drug production, and entrusted drug production, subject to approval [1] - Additional services include technology import and export, goods import and export, technical services, research and development in natural sciences, software development, and sales of pharmaceutical equipment [1] Location and Registration - The company is located in the Suzhou Dushu Lake Science and Education Innovation District, specifically at 1280 Shijinggang Road, New Index Workshop, Biopharmaceutical Industry Park, Phase 7, Room 601 [1] - The business registration is valid until August 20, 2025, with no fixed term thereafter [1]